Search

Your search keyword '"Stanciu, C."' showing total 683 results

Search Constraints

Start Over You searched for: Author "Stanciu, C." Remove constraint Author: "Stanciu, C."
683 results on '"Stanciu, C."'

Search Results

1. Can green endoscopy be implemented in Romania? – Results of a single-center survey

2. Idiopathic Cervical Esophageal Webs: A Case Report and Literature Review

3. Athermal All-Optical Femtosecond Magnetization Reversal in GdFeCo

7. Seasonal observations of the ocean and sea ice environment offshore Oliktok Point, Alaska, using distributed acoustic sensing

11. The relevance of oxidative stress in cirrhotic patients with different forms of hepatic encephalopathy

14. Raport ini��ial privind distribu��ia speciilor de nevertebrate terestre alogene rezultat�� din activitatea de inventariere cu efort redus (an 1 cartare)

15. Raport ini��ial privind distribu��ia speciilor de nevertebrate terestre alogene din hot-spot-uri ��i c��ile prioritare de p��trundere (an 1 cartare)

16. Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II)

26. CDEIS score of 2 is optimal cut-off associated with lower risk of disease progression in early Crohn's disease : Data from the CALM study

28. P240 CDEIS score of 2 is optimal cut-off associated with lower risk of disease progression in early Crohn’s disease: Data from the CALM study

32. Endoscopic and deep remission at 1 year prevents disease progression in early Crohn's disease : long-term data from CALM

33. Impact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: Results from the GUARD-C Cohort

34. OP35 Endoscopic and deep remission at 1 year prevents disease progression in early Crohn’s disease: long-term data from CALM

37. Risk of early de-novo hepatocellular carcinoma (HCC) in patients with genotype-1b HCV compensated cirrhosis treated with 3 direct-acting antivirals (DAAs) – a real life, multicenter study

44. A low incidence of hepatocellular carcinoma in patients with genotype 1b compensated cirrhosis treated with paritaprevir/ritonavir, ombitasvir and dasabuvir ± ribavirin in a tertiary center: a matter of better selection?

45. Predictors of persistence of clinical significant portal hypertension in patients with HCV liver cirrhosis following 3D therapy and SVR

46. Hepatic and non-hepatic events after obtaining a SVR in patients with genotype 1b liver cirrhosis-short time follow-up-single center experience

47. Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir with or without ribavirin (RBV) in hepatitis C virus genotype 1- infected patients with compensated cirrhosis and multiple comorbidities

48. Early regression of liver fibrosis evaluated by non-invasive methods after successful antiviral therapy in patients with HCV genotype 1b compensated cirrhosis

Catalog

Books, media, physical & digital resources